Cecilia Copparoni

Ancona, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Oncological Genetic Counseling in Hereditary Breast and Ovarian Cancers and Lynch Syndrome High-Risk Subjects: Evaluation of Efficacy and Outcomes Using the Genomics Outcome Scale.

Oncological Genetic Counseling in Hereditary Breast and Ovarian Cancers and Lynch Syndrome High-Risk Subjects: Evaluation of Efficacy and Outcomes Using the Genomics Outcome Scale.

Journal: Human mutation

Published: July 28, 2025

Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study.

Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study.

Journal: Current oncology (Toronto, Ont.)

Published: December 06, 2022

Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab.

Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab.

Journal: Frontiers in oncology

Published: July 04, 2021

BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma.

BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma.

Journal: Journal of thoracic disease

Published: March 29, 2021

Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer.

Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer.

Journal: Annals of translational medicine

Published: March 12, 2021

High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients.

High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 09, 2020

Impact of Polypharmacy for Chronic Ailments in Colon Cancer Patients: A Review Focused on Drug Repurposing.

Impact of Polypharmacy for Chronic Ailments in Colon Cancer Patients: A Review Focused on Drug Repurposing.

Journal: Cancers

Published: August 20, 2020

Questioning the prognostic role of BAP-1 immunohistochemistry in malignant pleural mesothelioma: A single center experience with systematic review and meta-analysis.

Questioning the prognostic role of BAP-1 immunohistochemistry in malignant pleural mesothelioma: A single center experience with systematic review and meta-analysis.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 17, 2020

Prospective observational study of taste assay in patients with solid tumors treated with standard chemotherapy (POTATO).

Prospective observational study of taste assay in patients with solid tumors treated with standard chemotherapy (POTATO).

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: February 18, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026